Exercise of options, PDMR shareholding & TVR | 20-Mar-2023 | 13:42 | RNS |
Director/PDMR Shareholding | 16-Mar-2023 | 13:34 | RNS |
Holding(s) in Company | 10-Mar-2023 | 13:49 | RNS |
Holding(s) in Company | 10-Mar-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 08-Mar-2023 | 14:09 | RNS |
Second Price Monitoring Extn | 02-Mar-2023 | 09:05 | RNS |
Price Monitoring Extension | 02-Mar-2023 | 09:00 | RNS |
Trading Update | 02-Mar-2023 | 07:00 | RNS |
Total Voting Rights | 28-Feb-2023 | 17:00 | RNS |
Exercise of options, director/PDMR & TVR | 03-Feb-2023 | 16:41 | RNS |
Employee Benefit Trust share transfer | 02-Feb-2023 | 08:48 | RNS |
Total Voting Rights | 31-Jan-2023 | 17:00 | RNS |
Further update re. North West London UTC contracts | 25-Jan-2023 | 11:07 | RNS |
Statement re publication in Health Service Journal | 24-Jan-2023 | 14:15 | RNS |
Dividend Declaration | 24-Jan-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 15.63p |
Change Today | -0.38p |
% Change | -2.34 % |
52 Week High | 47.60 |
52 Week Low | 15.00 |
Volume | 1,154,443 |
Shares Issued | 196.10m |
Market Cap | £30.64m |
RiskGrade | 368 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 02-Feb-23 | 08-Sep-22 |
Paid | 24-Feb-23 | 12-Oct-22 |
Amount | 0.50p | 0.50p |
Time | Volume / Share Price |
16:35 | 300 @ 15.75p |
15:36 | 25,000 @ 15.58p |
15:33 | 9,785 @ 15.63p |
15:08 | 1,000 @ 15.57p |
14:53 | 6,326 @ 15.63p |
CEO | Wendy Jayne Lawrence |
Chair | Robert (Bob) Holt |
Finance Director | Lisa Barter-Ng |
You are here: research